Carcinoid Tumors
January 2024 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Carcinoid Tumors abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Carcinoid Tumors. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Carcinoid Tumors. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Carcinoid Tumors every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Carcinoid heart disease: a potentially fatal complication of carcinoid syndrome.
Authors:Bdiwi M, Ramaseshan K, Uddin M, Goel M, Razzaq S, Alrayyashi M, Afonso L
Institution:Department of Internal Medicine, Wayne State University/ Detroit Medical Center, Detroit, Michigan, USA mbdiwi@med.wayne.edu.; Cardiology/Department of Internal medicine, Wayne State University/ Detroit Medical Center, Detroit, Michigan, USA.
Journal:BMJ Case Rep. 2023 Dec 6;16(12):e255518. doi: 10.1136/bcr-2023-255518.

2:Maintaining quality of life after major lung resection for carcinoid tumor.
Authors:Abdel Jalil R, Abdallah FA, Obeid Z, Abou Chaar MK, Harb AK, Shannies TB, El-Edwan A, Haddad H, Ghraibeh A, Abu-Shanab A
Institution:Department of Thoracic Oncology, King Hussein Cancer Center, Queen Rania Al Abdullah Street, P.O. Box 1269, Amman, 11941, Jordan. Da.06648@khcc.jo.
Journal:J Cardiothorac Surg. 2023 Nov 14;18(1):330. doi: 10.1186/s13019-023-02435-7.

3:Prevalence, one-year-incidence and predictors of carcinoid heart disease.
Authors:Mattig I, Franke MR, Pschowski R, Brand A, Stangl K, Knebel F, Dreger H
Institution:Deutsches Herzzentrum der Charite, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Charite Mitte, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany. henryk.dreger@dhzc-charite.de.
Journal:Cardiovasc Ultrasound. 2023 Sep 26;21(1):18. doi: 10.1186/s12947-023-00316-6.

4:Improving outcomes in carcinoid heart disease - learning from a single centre.
Authors:Cope J, Maclean R, Hota S, Ramage JK, Mullholland N, Clement D, Brown S, Piper S, MaCarthy P, Wendler O, Srirajaskanthan R
Institution:Department of Gastroenterology, King's College Hospital.
Journal:Nucl Med Commun. 2023 Nov 1;44(11):968-976. doi: 10.1097/MNM.0000000000001749. Epub 2023 Sep 4.

5:Carcinoid syndrome-Symptoms and therapeutic approaches.
Authors:Chrisoulidou A
Institution:Unit of Endocrinology, Theagenio Cancer Hospital, Thessaloniki, Greece. a.chrisoulidou@gmail.com.
Journal:Hell J Nucl Med. 2023 May-Aug;26 Suppl:52-56.

6:Bronchial carcinoid tumors in children and adolescents - A report and management considerations from the German MET studies.
Authors:Abele M, Kunstreich M, Lessel L, Seitz G, Vokuhl C, Lapa C, Schneider DT, Brecht IB, Redlich A, Kuhlen M
Institution:Pediatric Hematology/Oncology, Department of Pediatrics, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: michael.abele@med.uni-tuebingen.de.; Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany. Electronic address: michaela.kuhlen@uk-augsburg.de.
Journal:Lung Cancer. 2023 Sep;183:107320. doi: 10.1016/j.lungcan.2023.107320. Epub 2023 Aug 5.

7:Clinical efficacy of thermal ablation for the treatment of pulmonary carcinoid tumor: a propensity-matched analysis.
Authors:Yang H, Li M, Liu T, Luo L
Institution:Department of Internal Medicine, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
Journal:Int J Hyperthermia. 2023;40(1):2225817. doi: 10.1080/02656736.2023.2225817.

8:Atypical thymic carcinoid tumor with ectopic ACTH syndrome in a 33-year-old male patient: A rare case report and literature review.
Authors:Li LY, Zhao HY, Tong HC, Li YC, Xu HT, Ma S, Yang LH, Zhang WL, Wildes T, Wang E
Institution:Department of Pathology, the First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.; Department of Pathology, Duke University Medical Center, Durham, NC.
Journal:Medicine (Baltimore). 2023 Jun 2;102(22):e33847. doi: 10.1097/MD.0000000000033847.

9:Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.
Authors:Das S, Stockton SS, Hassan SA
Institution:Late Development Oncology, GI, AstraZeneca, Gaithersburg, MD, USA.; Ascension Texas Cardiovascular, Cedar Park, TX, USA.
Journal:Oncologist. 2023 Jul 5;28(7):575-583. doi: 10.1093/oncolo/oyad126.

10:Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study.
Authors:Kong S, Sun J, Sui X, Zhang S, Qi Y, Ma Y, Li S
Institution:Department of Obstetrics and Gynecology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Journal:Acta Obstet Gynecol Scand. 2023 Jul;102(7):935-941. doi: 10.1111/aogs.14578. Epub 2023 Apr 14.

11:Prognosis of Unresected vs Resected Small Pulmonary Carcinoid Tumors.
Authors:Roat-Shumway S, Tonelli CM, Baker MS, Abdelsattar ZM
Institution:Stritch School of Medicine, Loyola University Chicago, Maywood Illinois.; Stritch School of Medicine, Loyola University Chicago, Maywood Illinois; Department of Surgery, Loyola University Medical Center, Maywood, Illinois. Electronic address: zaid.abdelsattar@lumc.edu.
Journal:Ann Thorac Surg. 2023 Sep;116(3):553-561. doi: 10.1016/j.athoracsur.2023.04.008. Epub 2023 Apr 11.

12:Current Management of Carcinoid Tumor: When Is a Wedge Enough?
Authors:Collins ML, Okusanya O
Institution:Department of Surgery, Thomas Jefferson University Hospital, 1015 Walnut Street, Suite 620, Philadelphia, PA 19107, USA. Electronic address: https://twitter.com/micaelacollins.; Division of Thoracic Surgery, Department of Surgery, Thomas Jefferson University Hospital, 211 South 9th Street, Suite 300, Philadelphia, PA 19107, USA. Electronic address: Olugbenga.okusanya@jefferson.edu.
Journal:Thorac Surg Clin. 2023 May;33(2):159-164. doi: 10.1016/j.thorsurg.2023.01.008. Epub 2023 Feb 26.

13:Typical Carcinoid Tumor Cases Causing Ectopic ACTH Syndrome: Dramatic Response to Surgery.
Authors:Kankoç A, Şatır Türk M, Özkan D, Sayan M, Çelik A
Institution:Department of Thoracic Surgery, Gazi University, Ankara, Turkey.
Journal:Port J Card Thorac Vasc Surg. 2023 Apr 4;30(1):53-56. doi: 10.48729/pjctvs.258.

14:Carcinoid heart disease in patients with midgut neuroendocrine tumours.
Authors:Delhomme C, Walter T, Arangalage D, Suc G, Hentic O, Cachier A, Alkhoder S, François L, Lombard-Bohas C, Iung B, Ruszniewski P, de Mestier L
Institution:Universite Paris-Cite, Department of Cardiology, Bichat/Beaujon Hospital (APHP.Nord), ENETS Centre of Excellence, Paris/Clichy, France.; Universite Paris-Cite, Department of Pancreatology and Digestive Oncology, ENETS Centre of Excellence, Beaujon Hospital (APHP.Nord), Clichy, France.
Journal:J Neuroendocrinol. 2023 Apr;35(4):e13262. doi: 10.1111/jne.13262. Epub 2023 Apr 2.

15:Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid Tumors.
Authors:Vellani SD, Nigro A, Varatharajan S, Dworkin LD, Creeden JF
Institution:Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Journal:Molecules. 2023 Feb 22;28(5):2047. doi: 10.3390/molecules28052047.

16:Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies.
Authors:Vitale G, Carra S, Alessi Y, Campolo F, Pandozzi C, Zanata I, Colao A, Faggiano A, On Behalf Of The Nike Group
Institution:Department of Medical Biotechnology and Translational Medicine, University of Milan, 20122 Milan, Italy.
Journal:Int J Mol Sci. 2023 Feb 10;24(4):3610. doi: 10.3390/ijms24043610.

17:Prognostic factors for pulmonary carcinoid with positive lymph node after surgical resection: a SEER database study.
Authors:Wang X, Liu T, Chen J, Dang J
Institution:Department of Radiation Oncology, The First Hospital of China Medical University, 155 Nanjing Road, Heping District, Shenyang, 110001, China. dangjunsy@163.com.
Journal:Gen Thorac Cardiovasc Surg. 2023 Jul;71(7):409-417. doi: 10.1007/s11748-023-01910-1. Epub 2023 Jan 27.

18:Appendiceal Carcinoids in Children-Prevalence, Treatment and Outcome in a Large Nationwide Pediatric Cohort.
Authors:Duess JW, Lange A, Zeidler J, Blaser J, Dingemann C, Ure BM, Lacher M, Gosemann JH, Hofmann AD
Institution:Department of Pediatric Surgery, University of Leipzig, 04103 Leipzig, Germany.; Department of Pediatric Surgery, Medical School Hannover, 30625 Hannover, Germany.
Journal:Medicina (Kaunas). 2022 Dec 30;59(1):80. doi: 10.3390/medicina59010080.

19:Diagnosis and Treatment of Lung Neuroendocrine Neoplasms: Somatostatin Receptor PET Imaging and Peptide Receptor Radionuclide Therapy.
Authors:Park H, Subramaniam RM
Institution:Department of Radiology, Lahey Hospital and Medical Center, 41 Burlington Mall Road, Burlington, MA 01850, USA. Electronic address: hyesun.park@lahey.org.; Department of Medicine, Otago Medical School, Dunedin, 01 Great King Street, Central Dunedin, Dunedin 9016, New Zealand; Department of Radiology, Duke University, Davison Building, Durham, NC 27710, USA.
Journal:PET Clin. 2023 Apr;18(2):223-231. doi: 10.1016/j.cpet.2022.11.005. Epub 2022 Dec 28.

20:Carcinoid tumors outside the abdomen.
Authors:Koehler K, Iams WT
Institution:Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Journal:Cancer Med. 2023 Apr;12(7):7893-7903. doi: 10.1002/cam4.5564. Epub 2022 Dec 22.

21:The Past, Present, and The Future of Carcinoid Heart Disease.
Authors:Meir J, Michaud L, Frishman WH, Aronow WS
Institution:From the Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Vaslhalla, NY.
Journal:Cardiol Rev. 2023 Jul-Aug 01;31(4):193-198. doi: 10.1097/CRD.0000000000000475. Epub 2022 Dec 5.

22:The diagnostic and prognostic role of combined [(18)F]FDG and [(68)Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience.
Authors:Albano D, Dondi F, Bauckneht M, Albertelli M, Durmo R, Filice A, Versari A, Morbelli S, Berruti A, Bertagna F
Institution:Nuclear Medicine, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy. domenico.albano@unibs.it.
Journal:Eur Radiol. 2023 Jun;33(6):4167-4177. doi: 10.1007/s00330-022-09326-w. Epub 2022 Dec 8.

23:Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
Authors:Centonze G, Maisonneuve P, Simbolo M, Lagano V, Grillo F, Fabbri A, Prinzi N, Garzone G, Filugelli M, Pardo C, Mietta A, Pusceddu S, Sabella G, Bercich L, Mangogna A, Rolli L, Grisanti S, Benvenuti MR, Pastorino U, Roz L, Scarpa A, Berruti A, Capella C, Milione M
Institution:1st Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Journal:Histopathology. 2023 Jan;82(2):324-339. doi: 10.1111/his.14819. Epub 2022 Oct 26.

24:Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study.
Authors:Ferolla P, Berruti A, Spada F, Brizzi MP, Ibrahim T, Marconcini R, Giuffrida D, Amoroso V, La Salvia A, Vaccaro V, Faggiano A, Colao A, Volante M, Ghizzoni S, Mazzanti P, Houchard A, Fazio N
Institution:Multidisciplinary NET Center, Umbria Regional Cancer Network, Perugia, Italy.; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IRCCS, IEO, Milan, Italy.
Journal:Neuroendocrinology. 2023;113(3):332-342. doi: 10.1159/000526811. Epub 2022 Aug 31.

For a FREE PREVIEW of the Medifocus Guidebook on Carcinoid Tumors click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Carcinoid Tumors click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Carcinoid Tumors...
at a Special 25% Discount


Medifocus Guidebook on Carcinoid Tumors

Updated: January 11, 2024
133 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Carcinoid Tumors is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $39.95
  • Less 25% Discount = - $10.00
  • Discounted Price = $29.95(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $26.60
  • Less 25% Discount = - $6.65
  • Discounted Price = $19.95

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 25% discount when you order your Guidebook by phone.

To receive your 25% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

CT842015462

Coupon Expires: July 21, 2024



What Our Customers Are Saying...

"The MediFocus Guidebook on Carcinoid Tumors helped me prepare for my operation. It was reassuring to be able to communicate with my surgeon and the consulting doctors having knowledge about my condition."
P.T.
Newcastle, England


"The Guide is detailed and written in a way that the layman can readily understand. My wife, who has just had a Carcinoid Tumor removed, is reading it as I write this. It will be helpful in her recovery and ongoing therapy."
F.B.
Nanaimo, British Columbia


"The MediFocus Guidebook on Carcinoid Tumors was extremely informative and easy to understand. Now I'm able to discuss my condition with my doctor in an informed manner and make better decisions regarding my treatment."
J.P.F.
Agoura Hills, California



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2024 Medifocus, Inc. All rights reserved.